BrainsWay
BrainsWay are boldly advancing neuroscience with their proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder (OCD) and smoking addiction. BrainsWay are dedicated to leading through superior science and building on their unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological and addiction disorders are underway.
Latest BrainsWay Content
News
New Target Identified in Brain Stimulation for Depression
Researchers have identified a new target for transcranial magnetic stimulation used to treat depression, taking steps towards being able to personalize the treatment.
Article
Transcranial Magnetic Stimulation: A Different Approach for Mental Disorders
Discover how transcranial magnetic stimulation is gaining traction and acceptance as an effective therapy for treatment-resistant depression due to its high efficacy and safety.
Advertisement
